The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models
Open accessAbstract
Preclinical data highlight AZD1390 as a potentially powerful new therapy to enhance brain tumor patient responses to radiotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
Targeting the DNA Damage Response in Cancer
O’Connor, M. J. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.040 · Cited by 1,518
Linkage of ATM to Cell Cycle Regulation by the Chk2 Protein Kinase
Matsuoka, S. (1998) · Science · doi:10.1126/science.282.5395.1893 · Cited by 1,322
CEREBRAL BLOOD FLOW, BLOOD VOLUME AND OXYGEN UTILIZATION: NORMAL VALUES AND EFFECT OF AGE
LEENDERS, K. L., PERANI, D., LAMMERTSMA, A. A., HEATHER, J. D., BUCKINGHAM, P., JONES, T., HEALY, M. J. R., GIBBS, J. M., WISE, R. J. S., HATAZAWA, J., et al. (1990) · Brain · doi:10.1093/brain/113.1.27 · Cited by 1,093
The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis
Falck, J., Mailand, N., Syljuåsen, R. G., Bartek, J., & Lukas, J. (2001) · Nature · doi:10.1038/35071124 · Cited by 1,085
ATM Activation by Oxidative Stress
Guo, Z., Kozlov, S., Lavin, M. F., Person, M. D., & Paull, T. T. (2010) · Science · doi:10.1126/science.1192912 · Cited by 1,079
Mintun, M. A., Raichle, M. E., Kilbourn, M. R., Wooten, G. F., & Welch, M. J. (1984) · Annals of Neurology · doi:10.1002/ana.410150302 · Cited by 955
Survival in glioblastoma: a review on the impact of treatment modalities
Delgado-López, P. D., & Corrales-García, E. M. (2016) · Clinical and Translational Oncology · doi:10.1007/s12094-016-1497-x · Cited by 659
Farde, L., Eriksson, L., Blomquist, G., & Halldin, C. (1989) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1989.98 · Cited by 448
Lin, X., & DeAngelis, L. M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.60.9503 · Cited by 441
Herzog, K.-H., Chong, M. J., Kapsetaki, M., Morgan, J. I., & McKinnon, P. J. (1998) · Science · doi:10.1126/science.280.5366.1089 · Cited by 422
Golding, S. E., Rosenberg, E., Valerie, N., Hussaini, I., Frigerio, M., Cockcroft, X. F., Chong, W. Y., Hummersone, M., Rigoreau, L., Menear, K. A., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0519 · Cited by 385
Self-citationDemystifying Brain Penetration in Central Nervous System Drug Discovery: Miniperspective
Di, L., Rong, H., & Feng, B. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301297f · Cited by 304
Human brain atlas: For high‐resolution functional and anatomical mapping
Roland, P. E., Graufelds, C. J., Wǎhlin, J., Ingelman, L., Andersson, M., Ledberg, A., Pedersen, J., Åkerman, S., Dabringhaus, A., & Zilles, K. (1994) · Human Brain Mapping · doi:10.1002/hbm.460010303 · Cited by 252
Site-specific Phosphorylation Dynamics of the Nuclear Proteome during the DNA Damage Response
Bennetzen, M. V., Larsen, D. H., Bunkenborg, J., Bartek, J., Lukas, J., & Andersen, J. S. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900616-mcp200 · Cited by 236
ATM Kinase Inhibition Preferentially Sensitizes p53-Mutant Glioma to Ionizing Radiation
Biddlestone-Thorpe, L., Sajjad, M., Rosenberg, E., Beckta, J. M., Valerie, N. C. K., Tokarz, M., Adams, B. R., Wagner, A. F., Khalil, A., Gilfor, D., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3408 · Cited by 213
Self-citationVanillins--a novel family of DNA-PK inhibitors
Durant, S. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg753 · Cited by 174
Self-citationPurification and DNA binding properties of the ataxia-telangiectasia gene product ATM
Smith, G. C. M., Cary, R. B., Lakin, N. D., Hann, B. C., Teo, S.-H., Chen, D. J., & Jackson, S. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11134 · Cited by 173
Neuroreceptor Assay with Positron Emission Tomography: Equilibrium versus Dynamic Approaches
Huang, S.-C., Barrio, J. R., & Phelps, M. E. (1986) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1986.96 · Cited by 161
Species Independence in Brain Tissue Binding Using Brain Homogenates
Di, L., Umland, J. P., Chang, G., Huang, Y., Lin, Z., Scott, D. O., Troutman, M. D., & Liston, T. E. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.038778 · Cited by 160
Targeted cancer therapies based on the inhibition of DNA strand break repair
O’Connor, M. J., Martin, N. M. B., & Smith, G. C. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210879 · Cited by 147
ATM Activation in Normal Human Tissues and Testicular Cancer
Bártková, J., Bakkenist, C. J., Meyts, E. R., Skakkebæk, N. E., Sehested, M., Lukas, J., Kastan, M. B., & Bártek, J. (2005) · Cell Cycle · doi:10.4161/cc.4.6.1742 · Cited by 144
Abrogation of radioresistance in glioblastoma stem‐like cells by inhibition of ATM kinase
Carruthers, R., Ahmed, S. U., Strathdee, K. E., Gomez-Roman, N., Amoah-Buahin, E., Watts, C., & Chalmers, A. J. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.08.003 · Cited by 143
Fridén, M., Ducrozet, F., Middleton, B. J., Antonsson, M., Bredberg, U., & Hammarlund‐Udenaes, M. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.026377 · Cited by 140
Pike, K. G., Barlaam, B. C., Cadogan, E. B., Campbell, A. D., Chen, Y., Colclough, N., Davies, N. L., de-Almeida, C., Degorce, S. L., Didelot, M., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01896 · Cited by 138
Self-citationStructures of closed and open conformations of dimeric human ATM
Baretić, D., Pollard, H., Fisher, D. I., Johnson, C. M., Santhanam, B., Truman, C., Kouba, T., Fersht, A. R., Phillips, C., & Williams, R. L. (2017) · Science Advances · doi:10.1126/sciadv.1700933 · Cited by 133
Beckmann, N., Giorgetti, E., Neuhaus, A., Zurbruegg, S., Accart, N., Smith, P., Perdoux, J., Perrot, L., Nash, M., Desrayaud, S., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0510-8 · Cited by 131
Banerjee, S., Buhrlage, S. J., Huang, H., Deng, X., Zhou, W., Wang, J., Traynor, R., Prescott, A. R., Alessi, D. R., & Gray, N. S. (2013) · Biochemical Journal · doi:10.1042/bj20131152 · Cited by 87
Cellularly active N-hydroxyurea FEN1 inhibitors block substrate entry to the active site
Exell, J. C., Thompson, M. J., Finger, L. D., Shaw, S. J., Debreczeni, J. E., Ward, T. A., McWhirter, C. L., Sioberg, C., Molina, D. M., Abbott, W. M., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2148 · Cited by 82
Self-citationGood Timing in the Cell Cycle for Precise DNA Repair by BRCA1
Durant, S. T., & Nickoloff, J. A. (2005) · Cell Cycle · doi:10.4161/cc.4.9.2027 · Cited by 78
Self-citationMorgado-Palacin, I., Day, A., Murga, M., Lafarga, V., Antón, M. E., Tubbs, A., Chen, H.-T., Ergen, A. V., Anderson, R., Bhandoola, A., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aad8243 · Cited by 75
Self-citationRequirement for DNA Ligase IV during Embryonic Neuronal Development
Gatz, S. A., Ju, L., Gruber, R., Hoffmann, E. R., Carr, A. M., Wang, Z.-Q., Liu, C., & Jeggo, P. A. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1324-11.2011 · Cited by 73
Transient ATM Kinase Inhibition Disrupts DNA Damage–Induced Sister Chromatid Exchange
White, J. S., Choi, S., & Bakkenist, C. J. (2010) · Science Signaling · doi:10.1126/scisignal.2000758 · Cited by 66
Choi, S., Gamper, A. M., White, J. S., & Bakkenist, C. J. (2010) · Cell Cycle · doi:10.4161/cc.9.20.13471 · Cited by 65
Current and Investigational Drug Strategies for Glioblastoma
Ajaz, M., Jefferies, S., Brazil, L., Watts, C., & Chalmers, A. J. (2014) · Clinical Oncology · doi:10.1016/j.clon.2014.03.012 · Cited by 36
Ataxia telangiectasia mutated deficiency affects astrocyte growth but not radiosensitivity.
Gosink, E. C., Chong, M. J., & McKinnon, P. J. (1999) · PubMed · Cited by 34
UV Radiation Induces Delayed Hyperrecombination Associated with Hypermutation in Human Cells
Durant, S. T., Paffett, K. S., Shrivastav, M., Timmins, G. S., Morgan, W. F., & Nickoloff, J. A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00444-06 · Cited by 27
Self-citationBarazzuol, L., Rickett, N., Ju, L., & Jeggo, P. A. (2015) · Journal of Cell Science · doi:10.1242/jcs.171223 · Cited by 26
ATM serine-1981 phosphorylation is a plausible biomarker
Bakkenist, C. J., Beumer, J. H., & Schmitz, J. C. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1084205 · Cited by 7
Barazzuol, L., Rickett, N., Ju, L., & Jeggo, P. A. (2015) · Development · doi:10.1242/dev.131607 · Cited by 7
Cited by
DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
Huang, R.-X., & Zhou, P.-K. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0150-x · Cited by 1,198
Lang, X., Green, M. D., Wang, W., Yu, J., Choi, J. E., Jiang, L., Liao, P., Zhou, J., Zhang, Q., Dow, A., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0338 · Cited by 1,047
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Zhou, Y., Tao, L., Qiu, J., Xu, J., Yang, X., Zhang, Y., Tian, X., Guan, X., Cen, X., & Zhao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01823-2 · Cited by 720
DNA Repair Pathways in Cancer Therapy and Resistance
Li, L.-Y., Guan, Y.-D., Chen, X.-S., Yang, J.-M., & Cheng, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.629266 · Cited by 383
“Preclinical study demonstrated that ATM inhibitor AZD1390 enhanced the radiosensitivity of tumor cells and extended animal survival in preclinical brain tumor models (Durant et al., 2018).”
BackgroundDNA damage checkpoint kinases in cancer
Smith, H. L., Southgate, H., Tweddle, D. A., & Curtin, N. J. (2020) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2020.3 · Cited by 322
Metadata
- Authors
- Durant, S. T., Zheng, L., Wang, Y., Chen, K., Zhang, L., Zhang, T., Yang, Z., Riches, L., Trinidad, A. G., Fok, J. H. L., Hunt, T., Pike, K. G., Wilson, J., Smith, A., Colclough, N., Reddy, V. P., Sykes, A., Janefeldt, A., Johnström, P., Varnäs, K., Takano, A., Ling, S., Orme, J., Stott, J., Roberts, C., Barrett, I., Jones, G., Roudier, M., Pierce, A., Allen, J., Kahn, J., Sule, A., Karlin, J., Cronin, A., Chapman, M., Valerie, K., Illingworth, R., & Pass, M.
- Venue
- Science Advances
- Published
- 2018-06
- Volume
- 4
- Issue
- 6
- Pages
- eaat1719-eaat1719
- ISSN
- 2375-2548 (ISSN-L)
- OpenAlex
- W2809134358
- Cited by
- 309
- References
- 41
- FWCI
- 12.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.